Mitsubishi Ufj Asset Management (Uk) Ltd. Neogenomics Inc Transaction History

Mitsubishi Ufj Asset Management (Uk) Ltd.

$226 Million
Q4 2024

A detailed history of Mitsubishi Ufj Asset Management (Uk) Ltd. transactions in Neogenomics Inc stock. As of the latest transaction made, Mitsubishi Ufj Asset Management (Uk) Ltd. holds 56,000 shares of NEO stock, worth $812,000. This represents 0.41% of its overall portfolio holdings.

Number of Shares

56,000

Previous 48,000 16.67%

Holding current value

$812,000

Previous $708,000 30.23%

% of portfolio

0.41%

Previous 0.37%

11 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2024 Jan 17, 2025	BUY	$13.0 - $18.43 $104,000 - $147,440	8,000 Added 16.67%	56,000 $922,000
Q4 2023 Feb 08, 2024	BUY	$11.67 - $20.73 $81,690 - $145,110	7,000 Added 17.07%	48,000 $776,000
Q3 2023 Nov 02, 2023	BUY	$12.15 - $17.85 $60,750 - $89,250	5,000 Added 13.89%	41,000 $504,000
Q2 2023 Jul 27, 2023	BUY	$14.1 - $19.83 $225,600 - $317,280	16,000 Added 80.0%	36,000 $579,000
Q1 2023 May 02, 2023	BUY	$9.09 - $19.45 $181,800 - $389,000	20,000 New	20,000 $348,000
Q1 2022 May 10, 2022	SELL	$12.15 - $35.28 $340,200 - $987,840	-28,000 Closed	0 $0
Q3 2021 Oct 19, 2021	BUY	$41.66 - $52.52 $124,979 - $157,560	3,000 Added 12.0%	28,000 $1.35 Million
Q2 2021 Jul 20, 2021	BUY	$36.62 - $51.69 $915,499 - $1.29 Million	25,000 New	25,000 $1.13 Million
Q4 2020 Jan 26, 2021	SELL	$36.08 - $56.47 $1.37 Million - $2.15 Million	-38,000 Closed	0 $0
Q2 2020 Jul 23, 2020	BUY	$24.21 - $31.02 $121,050 - $155,100	5,000 Added 15.15%	38,000 $1.18 Million
Q1 2020 Apr 30, 2020	BUY	$20.5 - $34.53 $676,500 - $1.14 Million	33,000 New	33,000 $911,000

Others Institutions Holding NEO

# of Institutions

291

Shares Held

124M

Call Options Held

698K

Put Options Held

120K

View Full List

About NEOGENOMICS INC

Ticker NEO
Exchange NASDAQ
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 125,796,000
Market Cap $1.82B
Description
NeoGenomics, Inc. operates a network of cancer-focused testing laboratories in the United States, Europe, and Asia. It operates through, Clinical Services and Pharma Services segments. The company offers testing services to hospitals, reference labs, pathologists, oncologists, clinicians, pharmaceutical firms, and researchers. It provides cytoge...

More about NEO

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Mitsubishi Ufj Asset Management (Uk) Ltd., based on Form 13F filings with the SEC.

News

Stay updated on Mitsubishi Ufj Asset Management (Uk) Ltd. with notifications on news.

Account

Mitsubishi Ufj Asset Management (Uk) Ltd. Neogenomics Inc Transaction History